DPLO - Diplomat Pharmacy up 5% premarket on revenue beat August, 09 2019 08:22 AM Diplomat Pharmacy Inc. Diplomat Pharmacy (DPLO) Q2 results: Revenues: $1,287.6M (-9.1%); Specialty segment: $1,215.8M (-1.5%); PBM segment: $90.3M (-52.1%).More news on: Diplomat Pharmacy, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...